"The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48‐week randomized phase 4 study: STAR study"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48‐week randomized phase 4 study: STAR study

To compare a treat‐and‐extend (TAE) strategy with a fixed dosing regimen of intravitreal conbercept (IVC) for the management of treatment‐naïve polypoidal choroidal vasculopathy (PCV) patients. Click to show full abstract

Keywords: polypoidal choroidal; intravitreal conbercept; choroidal vasculopathy; study

Journal Title: Acta Ophthalmologica
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended